Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant RecipientsNCT06126380Eledon PharmaceuticalsPhase 2Enrolling by invitation2029-12Estimated
A Study to Evaluate ARD-501 in Patients With Autism Spectrum DisorderNCT06126653AARDPhase 2Completed2025-01-13Actual
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)NCT06127043ANABPhase 2Active not recruiting2026-01Estimated
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryNCT06128369OculisPhase 3Terminated2024-05-02Actual
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)NCT06128629Intellia TherapeuticsPhase 3Recruiting2027-12Estimated
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)NCT06132256Syndax PharmaceuticalsPhase 2Completed2026-08-27Actual
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic DermatitisNCT06136741NKTRPhase 2Active not recruiting2025-05-06Actual
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion SicknessNCT06138613Vanda PharmaceuticalsPhase 3Active not recruiting2027-09-30Estimated
Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye PressureNCT06144918SKYEPhase 2Completed2024-02-22Actual
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSANCT06146101Incannex Healthcare LtdPhase 2, Phase 3Completed2025-05-20Actual
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCLNCT06149247SoligenixPhase 2Completed2024-05-31Actual
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaNCT06150924MLYSPhase 2Completed2025-02-27Actual
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusNCT06152042BMEAPhase 2Completed2025-05-20Actual
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionNCT06152861Glaukos CorporationPhase 2Unknown2024-08Estimated
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionNCT06153693MLYSPhase 3Completed2024-12-10Actual
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyNCT06154252Cabaletta BioPhase 2, Phase 3Recruiting2028-07Estimated
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical CancerNCT06157151PGENPhase 2Recruiting2026-11-11Estimated
ACP-204 in Adults With Alzheimer's Disease PsychosisNCT06159673ACADPhase 2, Phase 3Recruiting2028-01Estimated
Influenza Viral Challenge Study of CC-42344 in Healthy ParticipantsNCT06160531COCPPhase 2Completed2024-05-03Actual
Study of Olutasidenib and Temozolomide in HGGNCT06161974Rigel PharmaceuticalsPhase 2Recruiting2029-06Estimated
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCNCT06162221RVMDPhase 1, Phase 2Recruiting2027-06Estimated
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPNCT06162286Zai Lab (Hong Kong), Ltd.Phase 3Unknown2025-01-01Estimated
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal PolypsNCT06164704UPBPhase 2Completed2025-07-07Actual
A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge ModelNCT06170242ENTAPhase 2Completed2024-06-17Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)NCT06172257OculisPhase 3Completed2026-04-02Actual
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06173531ACADPhase 3Completed2025-08-19Actual
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaNCT06179108LBRXPhase 2Completed2024-12-04Actual
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)NCT06181136DNLIPhase 1, Phase 2Recruiting2032-07Estimated
A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.NCT06185543NRSNPhase 2Terminated2025-09-30Actual
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)NCT06190093OTLKPhase 3Completed2024-11-07Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.